Erratum: Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL (Clinical Chemistry (2006) 52 (760-764) DOI: 10.1373/clinchem.2005.064337);Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL

Clinical Chemistry

Volumn 52, Issue 4, 2006, Pages 760-764

  Holvoet, Paul ^a   Macy, Elizabeth ^b   Landeloos, Michele ^a   Jones, Dan ^b   Nancy, Jenny S ^b   Van De Werf, Frans ^a   Tracy, Russell P ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL LABORATORY; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

EID: 33645451365     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.073601     Document Type: Erratum

References (16)

1. Goldstein JL, Brown MS. Molecular medicine. The cholesterol quartet. Science 2001;292:1310-2.
2. Mertens A, Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 2001;15:2073-84.
3. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804.
4. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002;22:1162-7.
5. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103:1955-60.
6. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998;98:1487-94.
7. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:844-8.
8. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, et al. Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000;20:2243-7.
9. Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003;41:360-70.
10. Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the health, aging, and body composition study. Arterioscler Thromb Vasc Biol 2003;23:1444-8.
11. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004;53:1068-73.
12. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005;112:651-7.
13. Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L. Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease. Int J Cardiol 2005 Dec 7 [Epub ahead of print].
14. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Amout J, et al. Correlation between oxidized low-density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 1996;76:663-9.
15. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001;47:444-50.
16. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.